Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2017-05-19

New medicine for rare eye disease

View source ↗

Summary

EMA announced a new medicine for a rare eye disease, indicating a regulatory approval or positive recommendation for treating a rare ocular condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications